De novo lipogenesis in health and disease

Metabolism: Clinical and Experimental

Volumn 63, Issue 7, 2014, Pages 895-902

  Ameer, Fatima ^a   Scandiuzzi, Lisa ^b   Hasnain, Shahida ^a   Kalbacher, Hubert ^c   Zaidi, Nousheen ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b Department of Radiation Oncology ^*  (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cancer; De novo lipogenesis; Fatty Acid Synthase; Non alcoholic fatty liver disease; Obesity

Indexed keywords

CANCER TISSUE; DE NOVO LIPOGENESIS; DISEASES; HEALTH; HUMAN; LIPOGENESIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

CANCER; DE NOVO LIPOGENESIS; FATTY ACID SYNTHASE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

ADIPOSE TISSUE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ENERGY METABOLISM; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIPID REGULATING AGENTS; LIPOGENESIS; LIVER; METABOLIC SYNDROME X; MOLECULAR TARGETED THERAPY; OBESITY; OPPORTUNISTIC INFECTIONS;

EID: 84902551389     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.04.003     Document Type: Review

References (80)

1. P. Bjorntorp, and L. Sjostrom Carbohydrate storage in man: speculations and some quantitative considerations Metabolism 27 12 Suppl. 2 1978 1853 1865
2. J.M. Schwarz, P. Linfoot, and D. Dare et al. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets Am J Clin Nutr 77 1 2003 43 50
3. I.J. Lodhi, X. Wei, and C.F. Semenkovich Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter Trends Endocrinol Metab 22 1 2011 1 8
4. A.P. Jensen-Urstad, and C.F. Semenkovich Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochim Biophys Acta 1821 5 2012 747 753
5. M.S. Strable, and J.M. Ntambi Genetic control of de novo lipogenesis: role in diet-induced obesity Crit Rev Biochem Mol Biol 45 3 2010 199 214
6. J. Schwarz, R. Neese, and S. Turner et al. Effect of fructose ingestion on glucose-production (GP) and de novo lipogenesis (DNL) in normal and hyperinsulinemic obese humans Diabetes 1994 Amer Diabetes Assoc. 1660 Duke St, Alexandria, VA 22314
7. L.C. Hudgins, C.E. Seidman, and J. Diakun et al. Human fatty acid synthesis is reduced after the substitution of dietary starch for sugar Am J Clin Nutr 67 4 1998 631 639
8. E.J. Parks, R.M. Krauss, and M.P. Christiansen et al. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance J Clin Invest 104 8 1999 1087 1096
9. F. Diraison, V. Yankah, and D. Letexier et al. Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans J Lipid Res 44 4 2003 846 853
10. S. Kersten Mechanisms of nutritional and hormonal regulation of lipogenesis EMBO Rep 2 4 2001 282 286
11. M.A. Herman, O.D. Peroni, and J. Villoria et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism Nature 484 7394 2012 333 338
12. K.S. Thompson, and H.C. Towle Localization of the carbohydrate response element of the rat L-type pyruvate kinase gene J Biol Chem 266 14 1991 8679 8682
13. W. Shao, and P.J. Espenshade Expanding roles for SREBP in metabolism Cell Metab 16 4 2012 414 419
14. N. Zaidi, I. Royaux, and J.V. Swinnen et al. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms Mol Cancer Ther 11 9 2012 1925 1935
15. D.B. Jump, S.D. Clarke, and A. Thelen et al. Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids J Lipid Res 35 6 1994 1076 1084
16. J. Swierczynski Leptin and age-related down-regulation of lipogenic enzymes genes expression in rat white adipose tissue J Physiol Pharmacol 57 Suppl. 6 2006 85 102
17. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 6704 1998 763 770
18. B.R. Barrows, and E.J. Parks Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states J Clin Endocrinol Metabol 91 4 2006 1446 1452
19. M. Lopez, S. Tovar, and M.J. Vazquez et al. Sensing the fat: fatty acid metabolism in the hypothalamus and the melanocortin system Peptides 26 10 2005 1753 1758
20. M. Lopez, C.J. Lelliott, and S. Tovar et al. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA Diabetes 55 5 2006 1327 1336
21. S. Wagle, A. Bui, and P.L. Ballard et al. Hormonal regulation and cellular localization of fatty acid synthase in human fetal lung Am J Physiol 277 2 Pt 1 1999 L381 L390
22. T. Kusakabe, M. Maeda, and N. Hoshi et al. Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells J Histochem Cytochem 48 5 2000 613 622
23. E.S. Pizer, R.J. Kurman, and G.R. Pasternack et al. Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium Int J Gynecol Pathol 16 1 1997 45 51
24. S.M. Anderson, M.C. Rudolph, and J.L. McManaman et al. Secretory activation in the mammary gland: it's not just about milk protein synthesis Breast Cancer Res 9 2007 204 217
25. C.D. Byrne Fatty liver: role of inflammation and fatty acid nutrition Prostaglandins Leukot Essent Fatty Acids 82 4-6 2010 265 271
26. F. Diraison, E. Dusserre, and H. Vidal et al. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity Am J Physiol Endocrinol Metab 282 1 2002 E46 E51
27. T.M. Loftus, D.E. Jaworsky, and G.L. Frehywot et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors Science 288 5475 2000 2379 2381
28. L.A. Adams, P. Angulo, and K.D. Lindor Nonalcoholic fatty liver disease CMAJ 172 7 2005 899 905
29. T. Mashima, H. Seimiya, and T. Tsuruo De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy Br J Cancer 100 9 2009 1369 1372
30. S. Zakhari Bermuda Triangle for the liver: alcohol, obesity, and viral hepatitis J Gastroenterol Hepatol 28 Suppl. 1 2013 18 25
31. N. Willemarck, E. Rysman, and K. Brusselmans et al. Aberrant activation of fatty acid synthesis suppresses primary cilium formation and distorts tissue development Cancer Res 70 22 2010 9453 9462
32. Y. Yu, A.J. Clippinger, and J.C. Alwine Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection Trends Microbiol 19 7 2011 360 367
33. N.S. Heaton, R. Perera, and K.L. Berger et al. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis Proc Natl Acad Sci U S A 107 40 2010 17345 17350
34. G. Aragones, C. Alonso-Villaverde, and C. Oliveras-Ferraros et al. Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infection BMC Gastroenterol 10 1 2010 92 101
35. J. Choudhury, and A.J. Sanyal Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease Clin Liver Dis 8 3 2004 575 594 [ix]
36. R.S. Rector, J.P. Thyfault, and Y. Wei et al. Non-alcoholic fatty liver disease and the metabolic syndrome: an update World J Gastroenterol 14 2 2008 185 192
37. A. Seppala-Lindroos, S. Vehkavaara, and A.M. Hakkinen et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men J Clin Endocrinol Metab 87 7 2002 3023 3028
38. L. Ryysy, A.M. Hakkinen, and T. Goto et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients Diabetes 49 5 2000 749 758
39. P.E. Carey, J. Gerrard, and G.W. Cline et al. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production Am J Physiol Endocrinol Metab 289 6 2005 E941 E947
40. K.M. Utzschneider, and S.E. Kahn Review: the role of insulin resistance in nonalcoholic fatty liver disease J Clin Endocrinol Metab 91 12 2006 4753 4761
41. G. Marchesini, R. Marzocchi, and F. Agostini et al. Nonalcoholic fatty liver disease and the metabolic syndrome Curr Opin Lipidol 16 4 2005 421 427
42. M. Adiels, S.O. Olofsson, and M.R. Taskinen et al. Diabetic dyslipidaemia Curr Opin Lipidol 17 3 2006 238 246
43. S.A. Polyzos, and C.S. Mantzoros Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease Metabolism 63 2 2014 161 167
44. G.F. Lewis, A. Carpentier, and K. Adeli et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes Endocr Rev 23 2 2002 201 229
45. B. Fromenty, M.A. Robin, and A. Igoudjil et al. The ins and outs of mitochondrial dysfunction in NASH Diabetes Metab 30 2 2004 121 138
46. D. Azzout-Marniche, D. Becard, and C. Guichard et al. Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes Biochem J 350 Pt 2 2000 389 393
47. V. Nobili, A. Alisi, and M. Raponi Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention World J Gastroenterol 15 48 2009 6017 6022
48. P. Tessari, A. Coracina, and A. Cosma et al. Hepatic lipid metabolism and non-alcoholic fatty liver disease Nutr Metab Cardiovasc Dis 19 4 2009 291 302
49. S. Petta, C. Muratore, and A. Craxi Non-alcoholic fatty liver disease pathogenesis: the present and the future Dig Liver Dis 41 9 2009 615 625
50. K.L. Donnelly, C.I. Smith, and S.J. Schwarzenberg et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 5 2005 1343 1351
51. M. Hamaguchi, T. Kojima, and N. Takeda et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease Ann Intern Med 143 10 2005 722 728
52. M.K. Hellerstein, C. Grunfeld, and K. Wu et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection J Clin Endocrinol Metab 76 3 1993 559 565
53. V. Kaddai, and F. Negro Current understanding of insulin resistance in hepatitis C Expert Rev Gastroenterol Hepatol 5 4 2011 503 516
54. L. Abu-Elheiga, M.M. Matzuk, and P. Kordari et al. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal Proc Natl Acad Sci U S A 102 34 2005 12011 12016
55. J. Mao, T. Yang, and Z. Gu et al. aP2-Cre-mediated inactivation of acetyl-CoA carboxylase 1 causes growth retardation and reduced lipid accumulation in adipose tissues Proc Natl Acad Sci U S A 106 41 2009 17576 17581
56. J. Mao, F.J. DeMayo, and H. Li et al. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis Proc Natl Acad Sci U S A 103 22 2006 8552 8557
57. M.V. Chakravarthy, Z. Pan, and Y. Zhu et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis Cell Metab 1 5 2005 309 322
58. M.V. Chakravarthy, Y. Zhu, and L. Yin et al. Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation J Lipid Res 50 4 2009 630 640
59. S.S. Chirala, H. Chang, and M. Matzuk et al. Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero Proc Natl Acad Sci U S A 100 11 2003 6358 6363
60. J. Munger, B.D. Bennett, and A. Parikh et al. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy Nat Biotechnol 26 10 2008 1179 1186
61. Y. Yu, T.G. Maguire, and J.C. Alwine Human cytomegalovirus infection induces adipocyte-like lipogenesis through activation of sterol regulatory element binding protein 1 J Virol 86 6 2012 2942 2949
62. N. Zaidi, J.V. Swinnen, and K. Smans ATP-citrate lyase: a key player in cancer metabolism Cancer Res 72 15 2012 3709 3714
63. W. Yang, B.L. Hood, and S.L. Chadwick et al. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production Hepatology 48 5 2008 1396 1403
64. C. Jackel-Cram, L.A. Babiuk, and Q. Liu Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core J Hepatol 46 6 2007 999 1008
65. Y. Li, J. Webster-Cyriaque, and C.C. Tomlinson et al. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression J Virol 78 8 2004 4197 4206
66. F.P. Kuhajda, E.S. Pizer, and J.N. Li et al. Synthesis and antitumor activity of an inhibitor of fatty acid synthase Proc Natl Acad Sci U S A 97 7 2000 3450 3454
67. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat Rev Cancer 7 10 2007 763 777
68. M. Buzzai, D.E. Bauer, and R.G. Jones et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation Oncogene 24 26 2005 4165 4173
69. M. Buzzai, R.G. Jones, and R.K. Amaravadi et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth Cancer Res 67 14 2007 6745 6752
70. R.J. DeBerardinis, J.J. Lum, and G. Hatzivassiliou et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation Cell Metab 7 1 2008 11 20
71. R.J. Deberardinis, N. Sayed, and D. Ditsworth et al. Brick by brick: metabolism and tumor cell growth Curr Opin Genet Dev 18 1 2008 54 61
72. E. Rysman, K. Brusselmans, and K. Scheys et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation Cancer Res 70 20 2010 8117 8126
73. X. Gao, and J. Zhang Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains Mol Biol Cell 19 10 2008 4366 4373
74. S.S. Stylli, A.H. Kaye, and P. Lock Invadopodia: at the cutting edge of tumour invasion J Clin Neurosci 15 7 2008 725 737
75. O.T. Fackler, and R. Grosse Cell motility through plasma membrane blebbing J Cell Biol 181 6 2008 879 884
76. S.J. Kridel, F. Axelrod, and N. Rozenkrantz et al. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity Cancer Res 64 6 2004 2070 2075
77. V. Chajes, M. Cambot, and K. Moreau et al. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival Cancer Res 66 10 2006 5287 5294
78. G. Hatzivassiliou, F. Zhao, and D.E. Bauer et al. ATP citrate lyase inhibition can suppress tumor cell growth Cancer Cell 8 4 2005 311 321
79. J. Hanai, N. Doro, and A.T. Sasaki et al. Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathways J Cell Physiol 227 4 2011 1709 1720
80. M.V. Chakravarthy, Y. Zhu, and M. Lopez et al. Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis J Clin Invest 117 9 2007 2539 2552